MRNA

Moderna

$28.09

+0.07 (+0.25%)
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...

Analyst Overview

Target Price:
Date: 19.08.2025
$45.60
(+62.34%)
Strong Buy: 1
Buy: 4
Hold: 16
Sell: 1
Strong Sell: 3
Description:
Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.
Exchange:
NASDAQ
Country:
USA
Sector:
LIFE SCIENCES
Industry:
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Address:
200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US
Fiscal year end:
December
Market capitalization:
$10.9 Billion
EBITDA:
-$3.06 Billion
PERatio:
0.0
EPS:
-7.51
Dividend per share:
$0.00
Dividend yield:
0.0%
Beta:
1.829

Dividends for 10 years

Loading...

Income Statements for 10 years

Loading...
Loading...

Earnings calender

Loading...

Income count if spend 1000$ ten years ago on shares

How much was you spent on shares:
$1,000
How much will you earn in 7 years:
+59%
How much will you get:
$1,589
Prices dates:
07-12-2018: $18.60 and 31-07-2025: $29.56